The category of VSTM5 Activators represents a group of diverse chemicals that are theorized to interact with and modulate the activity of the VSTM5 protein. This protein, based on its role and structure within cells, could be influenced by various biochemical compounds. The activators in this class are characterized by their ability to enhance VSTM5 activity, either through direct interaction with the protein or indirectly by affecting associated cellular pathways. Direct activators are thought to bind to VSTM5, altering its structure or stability, or its interactions with other cellular components, thereby increasing its functional activity. Indirect activators, conversely, are believed to affect VSTM5 through their influence on related signaling pathways or cellular processes, thereby indirectly modulating the protein's activity. These might include pathways involving intracellular signaling molecules like cAMP or calcium ions, or specific kinase activities, each impacting the cellular environment and, consequently, the activity of VSTM5.
Within this class, the chemicals are diverse, ranging from small organic compounds to more complex biomolecules. Some are speculated to mimic natural ligands or substrates of VSTM5, interacting with active or binding sites on the protein. Others might function allosterically, binding to sites distinct from the active site and inducing a functional change. The indirect activators in this group are considered capable of influencing VSTM5 activity by altering phosphorylation states, affecting gene expression, or changing the protein's cellular localization. They might modulate the activity of kinases or phosphatases upstream of VSTM5, affect transcriptional levels, or alter cellular redox states. There's also the possibility that some chemicals within this class could synergistically interact, leading to a more pronounced effect on VSTM5 activation. This diverse range of mechanisms reflects the intricate nature of protein regulation in cells, where numerous pathways and molecular interactions converge to determine a protein's activity. The VSTM5 Activators thus represent a conceptual group of chemicals, each potentially playing a role in the modulation of VSTM5 within cellular environments.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Le paclitaxel est un agent stabilisant les microtubules qui peut augmenter indirectement la VSTM5. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Le SB431542 est un inhibiteur sélectif du récepteur kinase du TGF-β de type I (ALK5), activant potentiellement VSTM5 par la voie du TGF-β. | ||||||
LY2109761 | 700874-71-1 | sc-396262 sc-396262A | 1 mg 5 mg | $87.00 $270.00 | 9 | |
LY2109761 est un double inhibiteur des kinases ALK5 et ALK4 du récepteur du TGF-β, qui peuvent réguler à la hausse le VSTM5 via la voie du TGF-β. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
La rapamycine est un immunosuppresseur qui inhibe la voie mTOR, activant potentiellement VSTM5 avec les voies liées à la mTOR. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
La cyclosporine A est un immunosuppresseur qui peut augmenter indirectement laVSTM5. | ||||||